In conclusion, the inactivation of Angptl4 in mice plays a protective role against the metabolic complications of diet-induced obesity, so that it is currently investigated as a therapeutic strategy for dyslipidemia and to improve glucose intolerance [108]. Here, ANGPTL4 is linked to obesity due to melanocortin 4 receptor deficiency.